Publication | Closed Access

Triphenyltin(IV) 2-[(E)-2-(aryl)-1-diazenyl]benzoates as anticancer drugs: synthesis, structural characterization, in vitro cytotoxicity and study of its influence towards the mechanistic role of some key enzymes

Medicinal ChemistryMechanistic RoleChemoprevention StrategyBiochemistryMedicineNatural SciencesKey EnzymesAnti-cancer AgentAnticancer DrugsDrug DevelopmentHeterocycle ChemistryPharmacologyDrug Discovery